Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06378801 · ClinicalTrials.gov registry record · NA
Radicle Relaxation 24: A Study of Health and Wellness Products on Stress and Related Health Outcomes
A NA study, sponsored by Radicle Science.
- Completed
- Registry status
- NA
- Development phase
- 1,700
- Enrollment target
NCT06378801: Completed NA study, sponsored by Radicle Science.
NCT06378801 is a NA study that has completed, run by Radicle Science. The registered enrollment target is 1,700 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (21% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06378801, a NA study, has completed, sponsored by Radicle Science.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,700 participants
- Enrollment target
Study Summary
A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on stress and related health outcomes
Primary Outcome
Mean difference in stress score as assessed by National Institutes of Health (NIH) Toolbox Perceived Stress Survey (scale 10-50; where lower scores correspond to less stress)
Interventions
- DIETARY_SUPPLEMENT Placebo Control Form 1
- DIETARY_SUPPLEMENT Placebo Control Form 2
- DIETARY_SUPPLEMENT Placebo Control Form 3
- DIETARY_SUPPLEMENT Relaxation Active Study Product 1.1
- DIETARY_SUPPLEMENT Relaxation Active Study Product 2.1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,700 participants |
| Start Date | 2024-02-29 |
| Est. Completion | 2024-11-01 |
| Phase | NA |
What the finished NCT06378801 record still lists
NCT06378801 is an interventional study that assigns participants to a tested intervention. Its 1,700 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (21% higher).
The record links to 0 conditions, and to 5 interventions - of which Placebo Control Form 1 is the first listed.
NCT06378801 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06378801 about?
NCT06378801 is a clinical study titled "Radicle Relaxation 24: A Study of Health and Wellness Products on Stress and Related Health Outcomes". A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on stress and related health outcomes
What is the current status of trial NCT06378801?
This trial is currently completed. It is a NA study. The enrollment target is 1,700 participants. The study started on 2024-02-29. Estimated completion is 2024-11-01.
What interventions are being tested in trial NCT06378801?
The interventions under investigation include: Placebo Control Form 1 (DIETARY_SUPPLEMENT), Placebo Control Form 2 (DIETARY_SUPPLEMENT), Placebo Control Form 3 (DIETARY_SUPPLEMENT), Relaxation Active Study Product 1.1 (DIETARY_SUPPLEMENT), Relaxation Active Study Product 2.1 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06378801?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06378801's enrollment target sits among peer trials
1,700 62nd of 2000 higher than 1,939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04321200 · 1,700 participants
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
- NCT06238622 · 1,700 participants · Phase 3
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
- NCT07284901 · 1,700 participants · Phase 3
Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- NCT07304531 · 1,705 participants
First To Know Pregnancy Test - Clinical Evaluation Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI